Proshares Ultra Nasdaq Biotech

BIB

About

BIB provides 2x daily exposure to a modified market-cap-weighted index of biotechnology and pharmaceutical companies listed on NASDAQ.

Name
ProShares Ultra Nasdaq Biotechnology
Index tracked
NASDAQ Biotechnology TR USD
Type
Other
Expense ratio
1.17%
Management fee
0.75%
Dividend policy
Quarterly
NAV
USD 111.0533 (10/15/2026)
Issued units
840.00K (10/16/2026)
Listing date
Apr 6, 2010
Sponsor
ProShares
Custodian
JPMorgan Chase Bank, N.A.

ETF Documents

Last updatedType
08/07/2026Annual Report
07/20/2026Prospectus